trending Market Intelligence /marketintelligence/en/news-insights/trending/a6H9G5qw_NioZm2sa6q0iw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

UK drugs association drops legal battle over new cost constraints

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


UK drugs association drops legal battle over new cost constraints

The Association of the British Pharmaceutical Industry's board unanimously agreed to not appeal a high court's decision to turn down its application for a judicial review of the National Institute for Health and Care Excellence's new cost rules for drugs.

Previously, the trade association of biopharmaceutical companies in the U.K. sought to challenge NICE's policy that limits funding of drugs expected to cost the U.K.'s National Health Service more than £20 million per year in any of the first three years of use.

The application was rejected by High Court Honourable Justice Elisabeth Laing.